Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1987 Mar;79(Suppl):17–22.

Risk factors in the management of the unique hypertensive patient.

J T Wright Jr
PMCID: PMC2625452  PMID: 3586055

Full text

PDF
17

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amery A., Birkenhäger W., Bulpitt C., Clement D., Deruyttere M., De Schaepdryver A., Dollery C., Fagard R., Forette F., Forte J. Influence of anti-hypertensive therapy on serum cholesterol in elderly hypertensive patients. Results of trial by the European Working Party on High blood pressure in the Elderly (EWPHE). Acta Cardiol. 1982;37(4):235–244. [PubMed] [Google Scholar]
  2. Berglund G., Andersson O. beta-blockers or diuretics in hypertension? A six year follow-up of blood pressure and metabolic side effects. Lancet. 1981 Apr 4;1(8223):744–747. doi: 10.1016/s0140-6736(81)92624-6. [DOI] [PubMed] [Google Scholar]
  3. Cutler R. Effect of antihypertensive agents on lipid metabolism. Am J Cardiol. 1983 Feb 24;51(4):628–631. doi: 10.1016/s0002-9149(83)80199-4. [DOI] [PubMed] [Google Scholar]
  4. Frishman W. H., Michelson E. L., Johnson B. F., Poland M. P. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension. Am J Med. 1983 Oct 17;75(4A):54–67. doi: 10.1016/0002-9343(83)90137-7. [DOI] [PubMed] [Google Scholar]
  5. Goldman A. I., Steele B. W., Schnaper H. W., Fitz A. E., Frohlich E. D., Perry H. M., Jr Serum lipoprotein levels during chlorthalidone therapy. A Veterans Administration-National Heart, Lung, and Blood Institute cooperative study on antihypertensive therapy: mild hypertension. JAMA. 1980 Oct 10;244(15):1691–1695. doi: 10.1001/jama.244.15.1691. [DOI] [PubMed] [Google Scholar]
  6. Harron D. W., Jady K., Riddell J. G., Shanks R. G. Effects of alinidine, a novel bradycardic agent, on heart rate and blood pressure in man. J Cardiovasc Pharmacol. 1982 Mar-Apr;4(2):213–220. doi: 10.1097/00005344-198203000-00008. [DOI] [PubMed] [Google Scholar]
  7. Helderman J. H., Elahi D., Andersen D. K., Raizes G. S., Tobin J. D., Shocken D., Andres R. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes. 1983 Feb;32(2):106–111. doi: 10.2337/diab.32.2.106. [DOI] [PubMed] [Google Scholar]
  8. Helgeland A., Hjermann I., Leren P., Enger S., Holme I. High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study. Br Med J. 1978 Aug 5;2(6134):403–403. doi: 10.1136/bmj.2.6134.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Helgeland A. Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. Am J Med. 1980 Nov;69(5):725–732. doi: 10.1016/0002-9343(80)90438-6. [DOI] [PubMed] [Google Scholar]
  10. Holland O. B., Nixon J. V., Kuhnert L. Diuretic-induced ventricular ectopic activity. Am J Med. 1981 Apr;70(4):762–768. doi: 10.1016/0002-9343(81)90530-1. [DOI] [PubMed] [Google Scholar]
  11. Lewis G. R. The long-term management of hypertension with verapamil. Clin Exp Pharmacol Physiol Suppl. 1982;6:107–112. [PubMed] [Google Scholar]
  12. MacCarthy E. P., Bloomfield S. S. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects. Pharmacotherapy. 1983 Jul-Aug;3(4):193–219. doi: 10.1002/j.1875-9114.1983.tb03252.x. [DOI] [PubMed] [Google Scholar]
  13. Madias J. E., Madias N. E., Gavras H. P. Nonarrhythmogenicity of diuretic-induced hypokalemia. Its evidence in patients with uncomplicated hypertension. Arch Intern Med. 1984 Nov;144(11):2171–2176. [PubMed] [Google Scholar]
  14. Marlin G. E., Thompson P. J., Reddel H. K., Chow C. M., Cheng S. Bronchodilator activity of prazosin in patients with allergic rhinitis and asthma. Br J Clin Pharmacol. 1982 Mar;13(3):445–448. doi: 10.1111/j.1365-2125.1982.tb01400.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. McGonigle R. J., Williams L., Murphy M. J., Parsons V. Labetalol and lipids. Lancet. 1981 Jan 17;1(8212):163–163. doi: 10.1016/s0140-6736(81)90759-5. [DOI] [PubMed] [Google Scholar]
  16. McKenney J. M., Goodman R. P., Wright J. T., Jr, Rifai N., Aycock D. G., King M. E. The effect of low-dose hydrochlorothiazide on blood pressure, serum potassium, and lipoproteins. Pharmacotherapy. 1986 Jul-Aug;6(4):179–184. doi: 10.1002/j.1875-9114.1986.tb03473.x. [DOI] [PubMed] [Google Scholar]
  17. McKenney J. M., Goodman R. P., Wright J. T., Jr Use of antihypertensive agents in patients with glucose intolerance. Clin Pharm. 1985 Nov-Dec;4(6):649–656. [PubMed] [Google Scholar]
  18. Weinberger M. H. Antihypertensive therapy and lipids. Paradoxical influences on cardiovascular disease risk. Am J Med. 1986 Feb 14;80(2A):64–70. doi: 10.1016/0002-9343(86)90162-2. [DOI] [PubMed] [Google Scholar]
  19. Whelton P. K. Diuretics and arrhythmias in the Medical Research Council trial. Drugs. 1984 Oct;28 (Suppl 1):54–65. doi: 10.2165/00003495-198400281-00006. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES